DOCSLIB.ORG

Sports Doping

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sports Doping June 2012 SPORTS DOPING ALSO INSIDE THIS ISSUE: Summer challenge: science advocacy Profile of George Stark American Society for Biochemistry and Molecular Biology A CONFERENCE ASBMB MEMBERS SHOULD NOT MISS! Protein Folding in the Cell July 29 - August 3, 2012 Vermont Academy Saxtons River, Vermont RESEARCH, EXPLORE, INTERACT This conference will bring together a diverse group of scientists who seek to de ne how the conformations of cellular proteins are achieved and maintained, and what happens in the cell when aberrant protein conformations arise. By de nition, the scienti c presentations at this meeting emphasize the use of cutting- edge techniques in biochemistry, biophysics, and computational science, and in genetics, cell biology, and imaging technologies. Because a growing number of diseases are linked to alterations in protein folding and structure, there is a strong emphasis on the impact of speci c proteins in human health, aging, and disease. In addition to talks from known leaders in this eld, ample time is set-aside for formal and informal scienti c discussions and for highly interactive poster sessions. Conference Co-Organizers: Judith Frydman, PhD Jeffrey Brodsky, PhD Stanford University, Stanford, CA University of Pittsburgh, Pittsburgh, PA To register or for more information, please visit us at www.faseb.org/SRC SRC-ProtienFolding - ASBMB Ad 7x10.indd 1 5/1/2012 11:53:37 AM contents JUNE 2012 On the cover: ASBMB Today science writer Rajendrani Mukhopadhyay news reports on how cheating 3 President’s Message athletes are manipulating various aspects of molecular Thank you, ASBMB biology and medicine to 5 News from the Hill improve their performance. 8 100 meetings: It starts with you 6 Member Update Outgoing ASBMB President Suzanne features Pfeffer gives thanks and reflects on the 8 Sports doping: an extreme society’s successes game of biology during her term. 3 14 Meet Ruma V. Banerjee, new JBC associate editor 17 Fanning the fire: a profile of Angel S. Byrd 20 A conversation with George Stark’s enthusiasm NSF’s Parag Chitnis for understanding signaling pathways and developing 23 Stark raving mad for science: biochemical methods is a profile of George Stark infectious. 23 departments 27 Mentoring New committee gets to work 28 Lipid News What’s happening at the Lipid Corner 29 Journal News The Journal of Biological 29 JBC: Structure papers to require Chemistry soon will PDB validation reports require authors of 30 JLR: Marine microorganisms and structure papers to submit anti-inammatory fatty acids validation reports. 29 30 MCP: The evolution of unstructured protein interactions 32 Minority Affairs Advice for new grads entering the job market SUMMER 34 Education CHALLENGE Reaching out to minority science students 1 Message 36 Open Channels 50 States 100 Meetings It starts with you. 5 June 2012 ASBMB Today 1 onlinecv A monthly publication of www.asbmb.org/asbmbtoday The American Society for Biochemistry and Molecular Biology Officers Suzanne R. Pfeffer President Complementary skills: communicating Jeremy M. Berg President-Elect Last month, ASBMB Today contributor Aruni S. Arachchige Mark A. Lemmon Secretary Merle S. Olson Treasurer Don launched her online-only series about the skills that young Toni M. Antalis Treasurer-Elect scientists should acquire to advance their careers — both inside Council Members and outside of the lab. It seems her message resonated with Karen N. Allen Ruma V. Banerjee readers, as her introductory column was consistently one of the Benjamin F. Cravatt Michael A. Marletta David Sabatini John D. Scott most-read articles on the site. Don’t miss her column this month Melissa Starovasnik Wesley I. Sundquist about written and oral communication. Jonathan S. Weissman Ex-Officio Members Russell DeBose-Boyd Hongtao Yu The making of a Yes, indeed, our Co-chairs, 2012 Annual Meeting Program Committee science Peter J. Kennelly members are so Chair, Education and Professional Development Committee policy Joan W. Conaway accomplished Chair, Meetings Committee fellow Terri Kinzy that this month Chair, Membership Committee If you’ve ever met ASBMB Squire J. Booker science policy fellow Julie we had more Chair, Minority Affairs Committee McClure — say at the annual Bettie Sue Masters Chair, Public Affairs Advisory Committee meeting tweetup or on member news Charles Brenner BER NEWS Chair, Publications Committee Capitol Hill — you probably items than we wouldn’t describe her as shy. In the online issue, Martha J. Fedor, Editor-in-chief, JBC could print. Visit Herbert Tabor, Co-editor, JBC ASBMB Today contributor Pumtiwitt McCarthy Ralph A. Bradshaw profiles McClure to let us know how the gutsy A. L. Burlingame the online edition Co-editors, MCP woman went from the lab to the halls where laws MEM Edward A. Dennis are made and what kind of advice she has for to find out who’s Joseph L. Witztum Co-editors, JLR scientists in a variety of scenarios. A sneak peak: moving up and ASBMB Today Editorial Advisory Board “Stop referring to careers outside of academia as Alex Toker (Chair) ‘alternative.’ If only one out of 10 biology Ph.D.s who deserves a Mike Bradley Craig E. Cameron becomes tenured faculty at an R1 university, then A. Stephen Dahms Alex C. Drohat pat on the back. Ben Ellington Irwin Fridovich academia is the exception — not the rule.” MORE Richard W. Hanson Gerald Hart Peter Kennelly Carol C. Shoulders ASBMB Today Angela Hopp Editor [email protected] Big bucks for brain research Rajendrani Mukhopadhyay Sr. Science Writer / Editor ASBMB Today contributor Connor [email protected] Bamford reports on the happen- Erin Salb Production Coordinator [email protected] ings at the Seattle-based Allen Nancy J. Rodnan Director of Publications Institute for Brain Science, [email protected] which just got an infu- Barbara Gordon Executive Director [email protected] sion of $300 million from Microsoft co-founder Paul For information on advertising, contact Capitol Media Solutions at 800-517-0610 G. Allen, bringing his total or [email protected] financial investment in the independent research center to a reported $500 million. www.asbmb.org/asbmbtoday June 2012 president’sag Thank you, ASBMB BY SUZANNE PFEFFER t is hard to believe that my two-year new mentorship committee led by I stint as president of the American Fred Maxfield. We initiated ASBMB- Society for Biochemistry and Molecular sponsored career symposia around Biology will end in a few weeks’ time. the country, at which students and Without reservation, service to this postdoctoral fellows meet with society has been a rich and reward- alumni of their own institutions to ing experience. I have had a chance to learn about the breadth of career meet and work with some wonderful choices that await biochemistry and people, I have learned many lessons, molecular biology Ph.D.s. and I feel energized to continue to do I had the pleasure of support- what I can in support of the community ing the creation of new awards, of scientists at large. including the Alice and C.C. Wang I owe a special thanks to ASBMB Award for Excellence in Molecular staff members, who are outstanding Joan Geiling has been ASBMB’s Parasitology, the new Mildred Cohn meetings manager since 2004. and do so much behind the scenes to We have her to thank for all the Award for contributions to biochem- enable our society to operate smoothly. behind-the-scenes work on our istry using physical approaches, Our executive director, Barbara Gordon, annual meetings. and an enhanced award to honor has assembled a terrific team that works Herb Tabor for his lifelong service to together to produce our journals (overseen by Nancy ASBMB and the JBC. Rodnan), organize our meetings and workshops (over- Tabor is a truly remark- seen by Joan Geiling, Jlynn Frazier and Weiyi Zhao), able man— it has been and oversee our finances (Steve Miller). Thanks to a special treat for me every member of the to get to know him a ASBMB staff for all little better during my you do on our behalf. term. I am proud to have A great deal of the helped recruit new work accomplished by editors-in-chief— the ASBMB is done for the Journal of by volunteers who Biological Chemis- contribute their ideas, try (Martha Fedor) energy and time to and ASBMB Today make the world of sci- (Angela Hopp)— and ence a better place for also to have recruited all of us. To our council Under Ben Corb’s direction, a new director of members, committee ASBMB has had more than public affairs, Ben chairs and committee 250 visits with lawmakers since Corb. We have cre- members, thank you September 2010. ated a new Public for your good work Geoff Hunt, formerly an ASBMB Outreach Committee and willingness to give back. No one has enough time science policy fellow, now is the society’s outreach coordinator. led by Geoff Hunt, our these days, yet these ASBMB members find time to Next month, look for his new former public policy contribute. I enjoy participating in ASBMB committees outreach column in ASBMB fellow, and Lee Geh- because it gives me a chance to meet new people and Today. rke and established a interact with colleagues whom I would not normally June 2012 ASBMB Today 3 firstpresident’snagcontinuedcontinued have the opportunity to work with. The projects under- a valued contact taken require creative problem solving— a process that when science-funding most scientists enjoy. Teaming up with my counterparts issues arise. Since from different institutions helps me to feel that I am part Corb joined the of a much larger family of biochemists and molecular ASBMB in September biologists. We share a common language, culture and 2010, we have had lifestyle and share joys more than 250 visits and challenges alike.
Load more

Recommended publications
  • Twists and Turns in Protein Assembly
    Twists and Turns in Protein Assembly Professor Robert Fairman TWISTS AND TURNS IN PROTEIN ASSEMBLY In nerve cells, the accumulation of protein into bundles of insoluble fibres is the underlying cause of a number of neurodegenerative diseases. Professor Robert Fairman and his team at Haverford College are developing cutting edge techniques to unravel this process. Proteins are the building blocks of life. The leads to the death of particularly vulnerable genetic code within each cell of our bodies cells such as neurones – the elaborate and controls the sequence of molecules called sensitive cells in our brain. This is the basic amino acids, which assemble together mechanism that causes the debilitating and to form each protein. But this is only the currently untreatable neurological disorder first step. Amino acids are small charged Huntington’s disease, which is characterised molecules that interact with one another as by a disruption of normal movements and they join together to form strings of peptides a decline in mental ability, resulting in (polypeptides), which spontaneously develop dementia. into different structures known as secondary structures. This can involve the formation ‘The relationship of this aggregation to of sheets or helical spirals following certain disease is poorly understood, and differences rules determined by the order of the amino in protein structure may underlie differences acids. These secondary structures then in toxicity,’ Professor Fairman admits. ‘Many interact with one another to form larger neurodegenerative diseases (Alzheimer’s, tertiary structures of proteins that control Huntington’s, Parkinson’s) have a similar and mediate every aspect of cell function. underlying molecular mechanism of protein aggregation, involving the formation of ‘Ever since I was an undergraduate student, an extended polypeptide chain that can I’ve always been fascinated with a chemical aggregate through ß-sheet formation.’ view of biology,’ Professor Fairman tells As such, it is vital to understand how Scientia.
    [Show full text]
  • From the President's Desk
    Sept | Oct 2009 From the President’s desk: The Increasing Importance of Model Organism Research I’m sure you know this scenario: You’re at a party, and someone hears you’re a biologist, and asks, “What do you work on?” When this happens to me, and I respond that I study yeast, I frequently get the follow-up question that you have probably already anticipated: “Are you learning how to make better beer?” At that point, I offer my explanation about the value of studying model organisms, which in cludes the statement that my daughter, now 17, learned to repeat with me by the time she was 3: “Yeast are actually a lot like people.” If you study a model organism, whether it’s yeast, bacteria, phage, flies, worms, fish, plants, or something else, you probably have been in Fred Winston a similar situation when talking to someone who is not a scientist. There GSA President is little understanding among the general public about the value of studying a model organism. This is also true among some who we might think would better understand this issue. While you wouldn’t be surprised to learn that the person at this party was a lawyer or a businessperson, you might also not be too surprised if that person turned out to be a physician, or even a human biologist. Even among some biologists who understand the history of model organisms, there may be a lack of appreciation for what model organism research can contribute to future scientific understanding. For these scientists, model organi sms appear to be in the twilight of their usefulness with the advent of new sequencing technologies and other genome-wide, high-throughput approaches that can be used in human studies.
    [Show full text]
  • 'Epigenetic Landscape' Is Protective in Normal Aging, Impaired in Alzheimer's Disease 5 March 2018
    'Epigenetic landscape' is protective in normal aging, impaired in Alzheimer's disease 5 March 2018 compaction of chromosomes in the nucleus (called acetylation of lysine 16 on histone H4, or H4K16ac for short). Changes to the way H4K16ac is modified along the genome in disease versus normal aging brains may signify places for future drug development. Because changes in H4K16ac govern how genes are expressed, the location and amount of epigenetic alterations is called the "epigenetic landscape." "This is the first time that we have been able to look at these relationships in human tissue by using donated postmortem brain tissue from the Penn Brain Bank," said Shelley Berger, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine and a professor of Biology in the School of Arts and Sciences. "Our results Coronal section of human brain indicating the lateral establish the basis for an epigenetic link between temporal lobe (red circle) used in this study. Credit: aging and Alzheimer's disease." Coronal section of human brain indicating The lab of Shelley Berger, PhD, Perelman School of Medicine, Berger, also the director of the Penn Epigenetics University of Pennsylvania Institute, Nancy Bonini, PhD, a professor of Biology, and Brad Johnson, MD, PhD, an associate professor of Pathology and Laboratory Medicine, are co-senior authors of the new study. Although certain genetic variants increase the risk of Alzheimer's disease (AD), age is the strongest H4K16ac is a key modification in human health known risk factor. But the way in which molecular because it regulates cellular responses to stress processes of aging predispose people to AD, or and to DNA damage.
    [Show full text]
  • St. Geme Symposium Pediatrics, University of Sponsored by the Colorado, AMC Section of Developmental Biology
    Department of St. Geme Symposium Pediatrics, University of Sponsored by the Colorado, AMC Section of Developmental Biology September 10, 2020 2:00pm-4:00pm Speaking Schedule Introduction by Dr. Bruce Appel, Section Head, The St. Geme Symposium Developmental Biology will be held this year in association with the St. 2:00 Caleb Doll, PhD – Fragility in specification; roles for Geme Lectureship, an the RNA binding protein FMRP in gliogenesis annual event in honor of 2:15 Agnese Kocere – RBM8A deficiency in TAR syndrome Dr. Joseph St. Geme, a impacts the lateral plate mesoderm former Dean of the 2:30 Julia Derk, PhD – A critical role for Wnt suppression in School of Medicine. The the development of the arachnoid barrier of the purpose of the meninges Symposium is to 2:45 Kelly Sullivan, PhD – Normalization of Interferon introduce research Receptor Gene Dosage in Mouse Model of Down performed in the Section Syndrome of Developmental Biology 3:00 Yunus Ozekin – Exploring the Effects of Prenatal to our St. Geme Lecturer, ECigarette Exposure on Craniofacial Development Dr. Nancy Bonini, 3:15 Jessica Warns, PhD – Does NF‐Y regulate cilia gene members of the St. Geme networks? family and the Anschutz 3:30 Kayt Scott – Prdm8 regulates pMN progenitor Medical Campus specification for motor neuron and oligodendrocyte community. fates by modulating Shh signaling response 3:45 Peter Dempsey, PhD ‐ Cellular Plasticity of Intestinal Secretory Progenitors in Response to Injury Zoom link https://ucdenver.zoom.us/j/921 40407653 Developmental Biology faculty, post-doctoral fellows About the Section of and student’s biographical information: Developmental Biology: Dempsey, Peter, PhD - Associate Professor Dr.
    [Show full text]
  • Temporal Patterns of Short Non-Coding Rna Modifications And
    TEMPORAL PATTERNS OF SHORT NON-CODING RNA MODIFICATIONS AND EXPRESSION by AMMAR S. NAQVI A dissertation submitted to the Graduate School – Camden Rutgers, The State University of New Jersey In partial fulfillment of the requirements For the degree of Doctor of Philosophy Graduate Program in Computational and Integrative Biology Written under the direction of Dr. Andrey Grigoriev And approved by ________________________ Andrey Grigoriev ________________________ Jongmin Nam ________________________ Nancy Bonini Camden, New Jersey May 2015 ABSTRACT OF THE DISSERTATION Temporal Patterns of non-coding RNA Modifications and Expression by AMMAR S. NAQVI Dissertation Director: Dr. Andrey Grigoriev We investigated the function and properties of small RNAs, particularly microRNAs and tRNA-derived fragments (tRFs) with age. We report the characterization of a novel 3'-to- 5' exonuclease, Nibbler (Nbr), that generates differing isoforms of miRNAs in Drosophila. We developed a robust approach to help identify and characterize 3' heterogeneity in microRNAs controlled by Nbr, which assisted in identifying age- associated traits, including neurodegeneration and lifespan. Subsequently, given the fact Nbr interacts with Ago1 and not Ago2, we observed an accumulation of certain isoforms, which lead us to ask if there were particular patterns and trends that were Ago-specific. Interestingly, we report a novel age-associated change of select isoforms with age that is Ago2 specific. RNA deep-sequencing analysis coupled with experimental evidence reflected an increased loading of miRNA isoforms into Ago2 with age. Essentially, the loss of methylated miRNAs led to accelerated brain degeneration and shortened lifespan. Intriguingly, we also observed and identified Ago-loaded tRFs, which appear to have properties similar to those of miRNAs.
    [Show full text]
  • TFEB/Mitf Links Impaired Nuclear Import to Autophagolysosomal
    RESEARCH ARTICLE TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9- ALS Kathleen M Cunningham1, Kirstin Maulding1, Kai Ruan2, Mumine Senturk3, Jonathan C Grima4,5, Hyun Sung2, Zhongyuan Zuo6, Helen Song2, Junli Gao7, Sandeep Dubey2, Jeffrey D Rothstein1,2,4,5, Ke Zhang7, Hugo J Bellen3,6,8,9,10, Thomas E Lloyd1,2,5* 1Cellular and Molecular Medicine Program, School of Medicine, Johns Hopkins University, Baltimore, United States; 2Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, United States; 3Program in Developmental Biology, Baylor College of Medicine (BCM), Houston, United States; 4Brain Science Institute, School of Medicine, Johns Hopkins University, Baltimore, United States; 5Solomon H. Snyder Department of Neuroscience, School of Medicine, Johns Hopkins University, Baltimore, United States; 6Department of Molecular and Human Genetics, BCM, Houston, United States; 7Department of Neuroscience, Mayo Clinic, Jacksonville, United States; 8Department of Neuroscience, BCM, Houston, United States; 9Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, United States; 10Howard Hughes Medical Institute, Houston, United States Abstract Disrupted nucleocytoplasmic transport (NCT) has been implicated in neurodegenerative disease pathogenesis; however, the mechanisms by which disrupted NCT causes neurodegeneration remain unclear. In a Drosophila screen, we identified ref(2)P/p62, a key regulator of autophagy, as a potent suppressor of neurodegeneration caused by the GGGGCC hexanucleotide repeat expansion (G4C2 HRE) in C9orf72 that causes amyotrophic lateral sclerosis *For correspondence: [email protected] (ALS) and frontotemporal dementia (FTD). We found that p62 is increased and forms ubiquitinated aggregates due to decreased autophagic cargo degradation. Immunofluorescence and electron Competing interest: See microscopy of Drosophila tissues demonstrate an accumulation of lysosome-like organelles that page 18 precedes neurodegeneration.
    [Show full text]
  • Polyq Expansions in Ataxin-2—A Risk Factor for Amyotrophic Lateral Sclerosis?
    RESEARCH HIGHLIGHTS MOTOR NEURON DISEASE PolyQ expansions in ataxin-2—a risk factor for amyotrophic lateral sclerosis? ntermediate-length polyglutamine (polyQ) expansions in the ataxin-2 I(ATXN2) gene could confer an increased risk of developing amyotrophic lateral sclerosis (ALS), according to research from a team led by Aaron Gitler and Nancy Bonini at the University of Pennsylvania, USA. Their findings indicate that ataxin-2 enhances the toxicity of TAR DNA-binding protein 43 (TDP-43)—a molecule that has already been strongly implicated in ALS pathogenesis—and the interaction between these two proteins could A combination of approaches involving yeast cells (left), Drosophila (center) and human motor neurons (right) has identified a provide a lead for the development of role for ataxin-2 in amyotrophic lateral sclerosis. Images provided by Professor Nancy Bonini and Professor Aaron Gitler. much-needed new therapies for ALS. Permission obtained from Nature Publishing Group © Elden, A. C. et al. Nature 466, 1069–1075 (2010). Long polyQ expansions (>34 glutamines) in the ATXN2 gene have overexpressed, increased TDP-43 toxicity. degradation, thereby increasing its previously been shown to cause the One of these genes was PBP1, the yeast concentration in the cell. hereditary neurodegenerative disease ortholog of ATXN2. These new findings identify ATXN2 spinocerebellar ataxia type 2 (SCA2). To examine the effects of the ATXN2– as a susceptibility gene for ALS, as well Gitler, Bonini and colleagues measured TDP-43 interaction in the context of as providing a number of avenues for ATXN2 polyQ repeat lengths in 915 the nervous system, the researchers further investigation of the underlying patients with sporadic or familial ALS, switched their attention to a Drosophila disease mechanisms.
    [Show full text]
  • NEWSLETTER VOLUME 35, NUMBER 6 Student/Postdoc- Led Local Meetings NIH Working Group Proposes Page 3 Training Changes More ASCB Award the Recommendations of a U.S
    ASCB J U L Y 2 0 1 2 NEWSLETTER VOLUME 35, NUMBER 6 Student/Postdoc- Led Local Meetings NIH Working Group Proposes Page 3 Training Changes More ASCB Award The recommendations of a U.S. National Institutes of Health (NIH) Working Group on the Announcements biomedical research workforce include changes in the programs offered by academic institutions, Page 8 limits on NIH support for graduate students, and changes in the way graduate students and postdocs are supported. The Working Group, a subcommittee of the Advisory Committee to An Innovative the NIH Director, was formed in January 2011 by NIH Director Francis Collins to examine Approach to Dual- the state of the biomedical research workforce and make recommendations to ensure the future Career Support competitiveness of the U.S. biomedical research enterprise. Page 11 The Biomedical Research Workforce Working Group was co-chaired by Shirley Tilghman and Sally Rockey, NIH Deputy Director for Extramural Research, and included ASCB members Leemor Joshua-Tor and Keith Yamamoto. In June 2012, the Working Group sent its report, with a series of recommendations, to Collins for his review and consideration. Inside Despite low unemployment for biomedical PhDs, the percentage of PhDs who move into President’s Column 3 tenured or tenure-track positions has declined by 8% since 1993. In contrast, science-related Did You Know? 6 occupations that do not involve the conduct of research or do not require graduate training WICB Junior, Senior Awards 8 are seeing increases in employment. According to
    [Show full text]
  • CV Yuanquan 3-23-16
    Yuanquan Song Ph.D. [email protected] Yuanquan Song Ph.D. Department of Physiology University of California San Francisco and HHMI 1550 4th Street RM RH481 San Francisco, CA 94158 (267) 679-9833 [email protected] Positions 05/2016 – Assistant Professor of Pathology and Laboratory Medicine Center for Cellular and Molecular Therapeutics (CCMT) at the Children's Hospital of Philadelphia (CHOP), University of Pennsylvania 09/2009 – 04/2016 Postdoctoral Fellow Dept. of Physiology, Univ. of California San Francisco and HHMI Mentor: Dr. Yuh Nung Jan, Ph.D. Education 05/2015 Spinal Cord Injury Training Program (SCITP) Dept. of Neuroscience, Ohio State University, Columbus, OH 2003 – 2009 Ph.D. in Neuroscience Univ. of Pennsylvania School of Medicine, Philadelphia, PA 1998 – 2002 B.S. in Biotechnology Shanghai Jiao Tong University, Shanghai, China Research Experience 09/2009 – present UCSF Yuh Nung Jan Lab Postdoctoral Fellow Research Projects: Cellular and molecular mechanisms underlying axon and dendrite degeneration and regeneration Neural and molecular substrates for the plasticity of aggression 02/2004 – 08/2009 UPenn Rita Balice-Gordon Lab Graduate Student Research Projects: Cellular and molecular mechanisms underlying neural circuitry formation and function Zebrafish model of MLL leukemogenesis Zebrafish model of neurodegenerative diseases 09/2003 – 12/2003 UPenn Irwin Levitan Lab Pre-dissertation Laboratory Rotation Research Project: Regulation of sodium-potassium ATPase by its binding protein mSlob 06/2003 – 08/2003 UPenn Nancy Bonini Lab Pre-dissertation Laboratory Rotation Research Project: Molecular mechanisms of polyglutamine diseases 07/2002 – 05/2003 Institute of Neuroscience, Academy of Sciences, Shanghai, China Research Assistant in the Lab of Shu-Min Duan, Xiao-Bing Yuan, and Mu-Ming Poo Research Project: Axon guidance and Rho GTPase signaling Awards and Fellowships 1 Yuanquan Song Ph.D.
    [Show full text]
  • From the President's Desk
    JAN - FEB 2008 From the President’s desk: The Urbilateria Book Project Genetics is thriving as never before, spawning in recent years sub- disciplines such as genomics, bioinformatics, evo-devo, systems biology, and more. If genetics were a business, there would be much talk about its growing market share both in basic science, its traditional realm, and increasingly throughout the world of medicine (with significant upside potential). The ageless questions – how genomes evolved on Earth, how genotype programs phenotype, what makes each of us human but unique, how genetic knowledge can better our lives – suddenly seem less daunting, more like practical tasks. Unsurprisingly, some of the brightest young minds on the planet are striving to join this remarkable enterprise in what promises to be among its greatest years. The Genetics Society of America should be at the forefront of all these developments. Genetic advances continue to unify all biological sciences, and a forum is needed to provide wise counsel, to nurture the careers of young geneticists, to communicate with the public, and to improve education, so more individuals can bring a true understanding of the biological world to today’s issues. There are several steps the GSA must take to provide this needed leadership. First, we must reach out and welcome every person who works to understand how genomes operate. We not only want a diverse membership, we need one. Splintering may succeed within ecosystems, but a tropical rainforest of genetics will not advance the future of our science, which is striving for unification. Most of the time we will continue to revel in our favorite realms, but we need a Genetics Society capable of overseeing the full scope of genetic science placing it all in its proper perspective.
    [Show full text]
  • *HDSA/Fall 01/Marker/C
    THE markerHuntington’s Disease Society of America HDSA Research Update 2001 progress hd living in research kids at-risk care a message from n the 1960’s, activist and entertainer In our Nation’s Capital, HDSA advocacy Truly, the answers Woody Guthrie was well known efforts have been unflagging. As a result of we find for Ithroughout the world, but the disease our awareness building efforts, HDSA was Huntington’s that ended his life was not. One of the invited by Connecticut Senator Disease may well greatest challenges that faced Marjorie Christopher Dodd in March to testify serve as the key to Guthrie when she founded the before his Senate Biotechnology caucus. effective therapies organization that was to become the In May, HDSA was invited to partner with or even cures for Huntington’s Disease Society of America the National Institute of Neurological all neuro- was the fact that HD was a “family” Disorders and Stroke (NINDS) in a pilot degenerative secret, misunderstood and often project that was reported in the last issue of and/or hereditary misdiagnosed. Educating healthcare Toward a Cure. In June, HDSA appeared at disorders. professionals, elected officials and the a Health Policy Briefing, hosted by the The HDSA Therapeutics Initiative will general public about Huntington’s National Health Council, along with bring the research, conducted by our Disease, and the challenges faced by several other voluntary health agencies, HDSA Coalition for the Cure those who live with it, has always been to bring issues of concern to the HD investigators and Grant and Fellowship an integral part of HDSA’s mission.
    [Show full text]
  • Enhanced Β Integrin Adhesion Underlies Thrombosis Risk in JAK2
    This Month CD40-targeting HIV vaccine attacks the latent reservoir 2 Neonatal Fc receptor antagonist safely reduces IgGs in healthy adults 3 Reversing B cell impairment in chronic hepatitis B infection 4 Intratumor NK cells respond to PD-1/PD-L1 blockade 5 October 2018 JCI This Month is a summary of the most recent articles in The Journal of Clinical Investigation and JCI Insight jci.org/this-month Enhanced β integrin adhesion underlies thrombosis risk in JAK2- Scan for the digital version V617F–driven neoplasms p. 2 of JCI This Month. Journal of Clinical Investigation Consulting Editors Soman N. Abraham Richard T. D'Aquila Katherine A. High Terri Laufer Sallie R. Permar Roy L. Silverstein John S. Adams Alan Daugherty Helen H. Hobbs Mitchell A. Lazar David J. Pinsky M. Celeste Simon Qais Al-Awqati Sudhansu Dey Ronald Hoffman Brendan Lee Edward Plow Mihaela Skobe Kari Alitalo Anna Mae Diehl V. Michael Holers William M.F. Lee Catherine Postic Donald Small Dario C. Altieri Harry C. Dietz III Steven Holland Rudolph L. Leibel Alice S. Prince Lois Smith Masayuki Amagai Gianpietro Dotti David Holtzman Wayne I. Lencer Louis J. Ptacek Akrit Sodhi Brian H. Annex Michael Dustin Michael J. Holtzman Jon D. Levine Luigi Puglielli Weihong Song M. Amin Arnaout Connie J. Eaves Lawrence B. Holzman Ross L. Levine Pere Puigserver Ashley L. St. John Alan Attie Dominique Eladari Maureen Horton Klaus Ley Bali Pulendran Jonathan Stamler Jane E. Aubin Joel K. Elmquist Tamas L. Horvath Rodger A. Liddle Ellen Puré Colin L. Stewart Michael F. Beers Stephen G.
    [Show full text]